港股异动|利福国际涨近4%中期纯利升44.8%至12.86亿港元
格隆汇8月16日丨利福国际(01212.HK)涨近4%,报9.33港元,成交3289万港元,总市值140亿港元。利福国际(01212.HK)公布,截至2019年6月30日止6个月,集团实现营业额21.03亿港元,同比下降1.8%;公司拥有人应占溢利12.86亿港元,同比增长44.8%;每股基本盈利0.856港元,宣派中期股息每股30.0港仙。期内公司拥有人应占溢利增幅乃主要由于回顾期间录得正投资收入4.27亿港元,而去年同期则因集团的金融投资产生公平值亏损,录得投资亏损5620万港元。由于零售环境较去年同期疲弱,销售收益轻微下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.